Nilay ŞAHİN, Ömer KARATAŞ, Murat ÖZKAYA, Ayşegül ÇAKMAK, Ender BERKER

6123

Servikal miyofasyal ağrı sendromlu hastalarda demografik özellikler, klinik bulgular ve fonksiyonel durum

Servikal bölgede miyofasyal ağrısı bulunan kişiler çeşitli klinik bulgularla karşımıza çıkabilirler. Bu çalışmanın amacı servikal miyofasyal ağrı sendromlu hastalarda demografik özellikler, klinik bulgular ve fonksiyonel durumu incelemektir. Kliniğimize başvuran 94 servikal miyofasyal ağrı sendromlu hasta değerlendirmeye alındı. Hastalarda kısa form-36 yaşam kalitesi (SF-36), ağrı, depresyon, demografik ve fiziksel özellikler değerlendirildi. Son durum ölçütleri; SF-36 yaşam kalitesi, görsel analog skala, Beck Depresyon İndeksi, anamnez ve fizik muayeneydi. Toplamda servikal miyofasyal sendrom tanısı almış 82 hasta çalışmaya dahil edildi. Hastaların hepsi genç olup yaş ortalamaları 37.4±9 ve %87.8’ I kadın idi. Hastaların %53.1’ i otonomik fenomen benzeri deri kızarıklığı, lakrimasyon ve vertigo ile birlikte trapezius kasında tetik noktaya sahipti. %58.5’ u önceden geçirilmiş servikal travmaya, %40.2’ si Fibromiyalji sendromuna ve %18.5’ u Benign eklem hipermobilite sendromuna sahipti. Otonomik fenomenler ve erken başlangıçlı servikal yaralanması bulunan genç, bayan hastalar servikal miyofasyal ağrı sendromu ve bu hastalarda da Fibromiyalji sendromu oranı yüksek olduğu için Fibromiyalji sendromu açısından değerlendirilmelidirler.
Anahtar Kelimeler:

Demografi, Fasiyal nöralji, Fibromiyalji, Ağrı ölçümü, Tetik nokta, Yaşam kalitesi, Kronik ağrı, Depresyon

Demographics features, clinical findings and functional status in a group of subjects with cervical myofascial pain syndrome

Subjects with myofascial pain of muscles of the neck region may present with various clinical symptoms. The aim of this study was to explore the demographics features, clinical findings and functional status in a group of patients presenting with myofascial pain of the cervical muscles. 94 cervical myofascial pain syndrome patients were recruited from the out-patient clinic. Evaluated of patient short form health survey (SF-36), pain, depression, patient demographics and physical examinations. Outcome measures; SF-36 Health Survey, visual analog scale, Beck Depression Inventory, history, physical examination. A total of 82 patients with a diagnosis of cervical myofascial syndrome were included in the study. All patients were in the young age group 37.4±9, and 87.8% were females. 53.1% had trigger points in the trapezius muscle with high percentage of autonomic phenomena like skin reddening, lacrimation, tinnitus and vertigo. 58.5% of the series had suffered from former cervical trauma and 40.2% also had Fibromyalgia syndrome and 18.5% had Benign Joint Hypermobility syndrome. Younger female patients presenting with autonomic phenomena and early onset cervical injury should be examined for cervical myofascial pain syndrome and also for Fibromyalgia syndrome since this study demonstrated a high percentage of Fibromyalgia syndrome in these patients.
Keywords:

Demography, Facial Neuralgia, Fibromyalgia, Pain Measurement, Trigger Points, Quality of Life, Chronic Pain, Depression,

PDF

___

  • Antonelli MA, Vawter RL : Nonarticular pain syndromes. Differentiating generalized, regional, and localized disorders. Postgrad Med 1992;91:95-98, 103-104.
  • Auleciems LM: Myofascial pain syndrome: a multidisiplinary approach. Nurse-Pract 1995;20:18-28.
  • Baldry PE, Inanici F, Hazleman B: The neck: Cervical myofascial trigger point pain syndrome. In: Baldry PE, editor. Myofascial Pain and Fibromyalgia Syndromes: A Clinical Guide to Diagnosis and Management. Churchill Livingstone, 2001. Pp. 121-134.
  • Bruce E: Myofascial pain syndrome: early recognition and comprehensive treatment. AAOHN J 1995; 43: 469-474.
  • Buskila D, Abramov G, Biton A, Neumann L: The prevalence of pain complaints in a general population in Israel and its implications for utulizitaion of health services. J Rheumatol 2000; 27: 1521-1525.
  • Elliott TE, Renier CM, Palcher JA: Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36. Pain Med 2003; 4: 331-339.
  • Escobar PL, Ballesteros J: Myofascial pain syndrome. Orthop Rev 1987; 16:708-713.
  • Evans RW: Some observations on whiplash injuries. Neurol Clin 1992; 10: 975-997.
  • Fishbain DA, Goldberg M, Steele R, Rosomoff H: DSM-III Diagnoses of patients with myofascial pain syndrome (fibrositis). Arch Phys Med Rehabil 1989; 70: 433-438.
  • Fricton JR, Steenks MH: Diagnosis and treatment of myofascial pain. Ned Tijdschr Tandheelkd 1996; 103: 249-253.
  • Fricton JR: Clinic care for myofascial pain. Dent Clin North Am 1991; 35: 1-28.
  • Gerwin RD: Classification, epidemiology, and natural history of myofascial pain syndrome. Curr Pain Headache Rep 2001; 5: 412-420.
  • Goldman JA: Hypermobility and deconditioning: important links to fibromyalgia/fibrositis. South Med J 1991; 84:1192-1196.
  • Grahame R, Brid H, Child A: The revised (Brighton 1998)Criteria for the Diagnosis of Benign Joint Hypermobility Syndrome. J Rheumatol 2000; 27: 1777-1779.
  • Han SC, Harrison P: Myofascial pain syndrome and trigger-point management. Reg Anesth 1997; 22: 89-101.
  • Hisli N: A validation study if Beck Depression Inventory [in Turkish]. Turk J Psychol 1988; 6: 118-126.
  • Hopwood MB, Abram SE: Factors associated with failure of trigger point injections. Clin J Pain 1994; 10: 227-234.
  • Hubbard DR, Berkoff GM: Myofascial trigger points show spontaneous needle activity. Spine 1993; 18: 1803-1807.
  • Hudson N, Starr MR, Esdaile JM, Fitzcharles MA: Diagnostic associations with hypermobility in rheumatology patients. Br J Rheumatol 1995; 34: 1157-1161.
  • Koçyiğit H, Aydemir Ö, Fişek G, Ölmez N, Memiş A: Kısa Form-36’ nın Türkçe versiyonunun geçerlilik ve güvenilirliği. ilaç ve Tedavi Dergisi 1999; 12: 102-106.
  • Kraus H, Fischer AA: Diagnosis and treatment of myofascial pain. Mt Sinai J Med 1991; 58: 235-239.
  • Kung YY, Chen FP, Chaung HL, Chou CT, Tsai YY, Hwang SJ:Evaluation of acupuncture effect to chronic myofascial pain syndrome in the cervical and upper back regions by the concept of Meridians. Acupunct Electrother Res 2001; 26: 195-202.
  • Lang AM: A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review. Clin Ther 2003; 25: 2268-2278.
  • Magnusson T: Extracervical symptoms after whiplash trauma.Cephalalgia 1994; 14: 223-227.
  • Marini I, Fairplay T, Vecchet F, Checci L: The treatment of trigger points in the cervical and facial area.J Musculoskeletal Pain 1999; 7: 239-245.
  • Meyer HP: Myofascial pain syndrome and its suggested role in the pathogenesis and treatment of fibromyalgia syndrome. Curr Pain Headache Rep 2002; 6: 274-283.
  • Porta MA: Comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000; 85: 101-105.
  • Rachlin ES: Trigger Points. In: Rachlin ES, Rachlin IS, editors. Myofascial Pain and Fibromyalgia: trigger point management. St. Louis Toronto: Mosby, 2002. pp. 203-217.
  • Raphael KG, Marbach JJ, Klausner J: Myofascial face pain.Clinical characteristics of those with regional vs.widespread pain. J Am Dent Assoc 2000; 131: 161-171.
  • Simon DG : Muscular pain syndromes. Adv Pain Res Ther 1990;17: 1–14.
  • Simons DG, Travell JG, Simons LS: Myofascial Pain and Dysfunction; The Trigger Point Manual. Williams and Wilkins, Baltimore: 1999.
  • Skootsky SA, Jaeger B, Oye RK: Prevalence of myofascial pain in general internal medicine practice. West J Med 1989;151: 157-160.
  • Sola AE, Rosenberger MS, Gettys BB: Incidence of hypersensitive areas in posterior shoulder muscles: A survey of two hundred young adults. Am J Phys Med 1955;34:585-590.
  • Thompson JM: The diagnosis and treatment of muscle pain syndrome. In: Braddom RL, Buschbacher RM, Dumitru D, Johnson EW, Matthews D, Sinaki M, editors. Physical Medicine and Rehabilitation. Philadelphia: W.B.Saunders, 2000, pp. 934-956.
  • Ware JE Jr: SF-36 health survey update. Spine 2000; 25: 3130-3139.
  • Wheeler AH: Myofascial pain disorders: theory to therapy.Drugs 2004; 64: 45-62.
  • Winocur E, Gavish A, Emodi-Perlman A, Halachmi M, Eli I.Hypnorelaxation as treatment for myofascial pain disorder:A comparative study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 429-434.
  • Yap EC. Myofascial pain--an overview. Ann Acad Med Singapore 2007; 36: 43-48.
Ağrı-Cover
  • ISSN: 1300-0012
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2018
  • Yayıncı: Ali Cangül
Arşiv
Sayıdaki Diğer Makaleler

Akciğer kanserli hastaların ağrılarının tedavisinde transdermal fentanil ve yavaş salınımlı morfinin karşılaştırılması

TÜLÜN ÖZTÜRK, Kaan KARADİBAK, Deniz ÇATAL, Aydan ÇAKAN, Fevziye TUGSAVUL, Kadri ÇIRAK

Hastaya bakım veren sağlık çalışanlarının ağrı kontrolünde uyguladıkları girişimlerin değerlendirilmesi

Behiye Deniz BACAKSIZ, Lütfiye Pirbudak ÇÖÇELLİ, Nimet OVAYOLU, SERVET ÖZGÜR

Servikal miyofasyal ağrı sendromlu hastalarda demografik özellikler, klinik bulgular ve fonksiyonel durum

Nilay ŞAHİN, Ömer KARATAŞ, Murat ÖZKAYA, Ayşegül ÇAKMAK, Ender BERKER

Hypnic headache associated with medication overuse: Case report

Betül BAYKAN, Mustafa ERTAŞ

Unilateral lomber hiperhidrozisde sempatik radyofrekans nöroliz: Olgu sunumu

Züleyha Soytürk AŞIK, Başak Ceyda ORBEY, İbrahim AŞIK

Büyük oksipital sinir blokajı: Trigeminoservikal sistem ve primer başağrılarındaki klinik uygulamalar

Macit Hamit SELEKLER